Benzinga's Top Downgrades

by Lisa Levin, Benzinga Editor

July 28, 2014 8:58 AM | 1 min read | Make a Comment

Analysts at Sterne Agee downgraded DSW

DSW

from Neutral to Underperform. The target price for DSW is set to $23. DSW's shares closed at $27.16 on Friday. BMO Capital downgraded Pfizer

PFE

from Outperform to Market Perform. The target price for Pfizer has been lowered from $34 to $31. Pfizer's shares closed at $30.19 on Friday. Analysts at Canaccord Genuity downgraded AcelRx Pharmaceuticals

ACRX

from Buy to Hold. The target price for AcelRx Pharmaceuticals has been lowered from $16.00 to $8.00. AcelRx Pharmaceuticals' shares closed at $10.83 on Friday. Deutsche Bank downgraded Lear

LEA

from Buy to Hold. The target price for Lear has been raised from $100.00 to $103.00. Lear's shares closed at $99.00 on Friday.

Market News and Data brought to you by Benzinga APIs